Thyrocare Technologies Limited — Others, 31-07-2025: Shareholders meeting

Thyrocare Technologies Limited's 25th Annual General Meeting saw shareholders approve all resolutions. This includes the adoption of the audited financial statements for FY25 and the declaration of a dividend of ₹21 per equity share. Shareholders also approved the re-appointment of a director, ratification of cost auditor remuneration for FY26, approval for material related party transactions with Docon Technologies, and appointment of Secretarial Auditors. The company reported FY25 revenue of INR 687.35 crore (up 20% YoY) and profit of INR 89.98 crore (up 29%). Thyrocare achieved 100% NABL accreditation for its owned labs and bolstered reach through acquisitions.